Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Autor: Cahn, Pedro, Pozniak, Anton L, Mingrone, Horacio, Shuldyakov, Andrey, Brites, Carlos, Andrade-Villanueva, Jaime F, Richmond, Gary, Buendia, Carlos Beltran, Fourie, Jan, Ramgopal, Moti, Hagins, Debbie, Felizarta, Franco, Madruga, Jose, Reuter, Tania, Newman, Tamara, Small, Catherine B, Lombaard, John, Grinsztejn, Beatriz, Dorey, David, Underwood, Mark, Griffith, Sandy, Min, Sherene
Zdroj: In The Lancet 24-30 August 2013 382(9893):700-708
Databáze: ScienceDirect